Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health [0.03%]
与健康信息技术及其他医疗设备相关的软件召回事件及对美国食品和药物管理局数字健康监管的启示
Jay G Ronquillo,Diana M Zuckerman
Jay G Ronquillo
Policy Points: Medical software has become an increasingly critical component of health care, yet the regulation of these devices is inconsistent and controversial. No studies of medical devices and software assess the impact on patient saf...
David Rosner
David Rosner
Constance A Nathanson,Henri Bergeron
Constance A Nathanson
Policy Points: Introducing a recent special issue of The Lancet on the health system in France, Horton and Ceschia observe that "the dominance of English as the language of science and, increasingly, global health too often closes the door ...
Epic Failure [0.03%]
史诗般的失败
Howard Markel
Howard Markel
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending [0.03%]
欧美市场中的通用名药物比较：价格、销量和支出
Olivier J Wouters,Panos G Kanavos,Martin McKEE
Olivier J Wouters
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United States. Regulators should make it easier for generic drugs to reach the market. Regulators and payers should a...
Comparative Study
The Milbank quarterly. 2017 Sep;95(3):554-601. DOI:10.1111/1468-0009.12279 2017
An Unhealthy Mismatch [0.03%]
不匹配的不良后果
Sandro Galea
Sandro Galea
John E McDONOUGH
John E McDONOUGH
Jonathan Cohn
Jonathan Cohn
Corrigendum [0.03%]
勘误表
Published Erratum
The Milbank quarterly. 2017 Sep;95(3):682. DOI:10.1111/1468-0009.12283 2017
David K Jones
David K Jones